These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 18829259)

  • 1. Levetiracetam in newly diagnosed late-onset post-stroke seizures: a prospective observational study.
    Belcastro V; Costa C; Galletti F; Autuori A; Pierguidi L; Pisani F; Calabresi P; Parnetti L
    Epilepsy Res; 2008 Dec; 82(2-3):223-6. PubMed ID: 18829259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levetiracetam monotherapy for late poststroke seizures in the elderly.
    Kutlu G; Gomceli YB; Unal Y; Inan LE
    Epilepsy Behav; 2008 Oct; 13(3):542-4. PubMed ID: 18539085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Add-on levetiracetam in children and adolescents with refractory epilepsy: results of an open-label multi-centre study.
    Callenbach PM; Arts WF; ten Houten R; Augustijn P; Gunning WB; Peeters EA; Weber AM; Stroink H; Geerts Y; Geerts AT; Brouwer OF
    Eur J Paediatr Neurol; 2008 Jul; 12(4):321-7. PubMed ID: 17950011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levetiracetam in juvenile myoclonic epilepsy: long-term efficacy in newly diagnosed adolescents.
    Verrotti A; Cerminara C; Coppola G; Franzoni E; Parisi P; Iannetti P; Aloisi P; Tozzi E; Cusmai R; Vigevano F; Chiarelli F; Curatolo P
    Dev Med Child Neurol; 2008 Jan; 50(1):29-32. PubMed ID: 18173626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levetiracetam versus carbamazepine in patients with late poststroke seizures: a multicenter prospective randomized open-label study (EpIC Project).
    Consoli D; Bosco D; Postorino P; Galati F; Plastino M; Perticoni GF; Ottonello GA; Passarella B; Ricci S; Neri G; Toni D;
    Cerebrovasc Dis; 2012; 34(4):282-9. PubMed ID: 23128439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levetiracetam for people with mental retardation and refractory epilepsy.
    Kelly K; Stephen LJ; Brodie MJ
    Epilepsy Behav; 2004 Dec; 5(6):878-83. PubMed ID: 15582836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levetiracetam in patients with epilepsy and chronic liver disease: observations in a case series.
    Bilo L; Meo R; de Leva MF; De Simone R; Di Nocera P; Pisani F; Striano S
    Clin Neuropharmacol; 2008; 31(4):221-5. PubMed ID: 18670245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and tolerability of levetiracetam versus phenytoin after supratentorial neurosurgery.
    Milligan TA; Hurwitz S; Bromfield EB
    Neurology; 2008 Aug; 71(9):665-9. PubMed ID: 18725591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjunctive levetiracetam in patients aged 1 month to <4 years with partial-onset seizures: subpopulation analysis of a prospective, open-label extension study of up to 48 weeks.
    Piña-Garza JE; Schiemann-Delgado J; Yang H; Duncan B; Hadac J; Hunter SJ
    Clin Ther; 2010 Oct; 32(11):1935-50. PubMed ID: 21095488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levetiracetam in clinical practice: long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy center.
    Bootsma HP; Ricker L; Diepman L; Gehring J; Hulsman J; Lambrechts D; Leenen L; Majoie M; Schellekens A; de Krom M; Aldenkamp AP
    Epilepsy Behav; 2007 Mar; 10(2):296-303. PubMed ID: 17317325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term use of Levetiracetam in patients with severe childhood-onset epilepsy.
    von Stuelpnagel C; Holthausen H; Kluger G
    Eur J Paediatr Neurol; 2007 Nov; 11(6):341-5. PubMed ID: 17442601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levetiracetam compared to valproic acid: plasma concentration levels, adverse effects and interactions in aneurysmal subarachnoid hemorrhage.
    Mink S; Muroi C; Seule M; Bjeljac M; Keller E
    Clin Neurol Neurosurg; 2011 Oct; 113(8):644-8. PubMed ID: 21703756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levetiracetam or oxcarbazepine as monotherapy in newly diagnosed benign epilepsy of childhood with centrotemporal spikes (BECTS): an open-label, parallel group trial.
    Coppola G; Franzoni E; Verrotti A; Garone C; Sarajlija J; Operto FF; Pascotto A
    Brain Dev; 2007 Jun; 29(5):281-4. PubMed ID: 17055681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of levetiracetam in the treatment of epilepsy.
    Brodie MJ; French JA
    Epileptic Disord; 2003 May; 5 Suppl 1():S65-72. PubMed ID: 12915344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and tolerability of levetiracetam in children younger than 4 years: a retrospective review.
    Perry MS; Benatar M
    Epilepsia; 2007 Jun; 48(6):1123-7. PubMed ID: 17430408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Open label, long-term, pragmatic study on levetiracetam in the treatment of juvenile myoclonic epilepsy.
    Specchio LM; Gambardella A; Giallonardo AT; Michelucci R; Specchio N; Boero G; La Neve A
    Epilepsy Res; 2006 Sep; 71(1):32-9. PubMed ID: 16814521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Once-daily extended-release levetiracetam as adjunctive treatment of partial-onset seizures in patients with epilepsy: a double-blind, randomized, placebo-controlled trial.
    Peltola J; Coetzee C; Jiménez F; Litovchenko T; Ramaratnam S; Zaslavaskiy L; Lu ZS; Sykes DM;
    Epilepsia; 2009 Mar; 50(3):406-14. PubMed ID: 19317886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in Chinese patients with refractory partial-onset seizures.
    Wu XY; Hong Z; Wu X; Wu LW; Wang XF; Zhou D; Zhao ZX; Lv CZ
    Epilepsia; 2009 Mar; 50(3):398-405. PubMed ID: 18657175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levetiracetam intravenous infusion as an alternative to oral dosing in patients with partial-onset seizures.
    Baulac M; Brodie MJ; Elger CE; Krakow K; Stockis A; Meyvisch P; Falter U
    Epilepsia; 2007 Mar; 48(3):589-92. PubMed ID: 17326794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levetiracetam extended release conversion to monotherapy for the treatment of patients with partial-onset seizures: a double-blind, randomised, multicentre, historical control study.
    Chung S; Ceja H; Gawłowicz J; Avakyan G; McShea C; Schiemann J; Lu S
    Epilepsy Res; 2012 Aug; 101(1-2):92-102. PubMed ID: 22516508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.